Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
390
NCT00102050
Efficacy and Safety of NM-702 Tablets for the Treatment of Intermittent Claudication
Phase: Phase 2
Role: Lead Sponsor
Start: Apr 30, 2003
Completion: Apr 30, 2006